I Need Your Help: Tell the FDA They Are Wrong About Estrogen

[madman]

Rachel Rubin, MD a urologist and sexual medicine specialist, discusses the critical need for physician and public engagement with the FDA on women's health. Learn how to advocate for the removal of inaccurate boxed warning labels on vaginal hormone therapies.

Dr. Rubin highlights the immense benefits and safety of vaginal estrogen and DHEA for treating genitourinary syndrome of menopause (GSM). She explains how these local therapies can prevent serious conditions like urinary tract infections and improve sexual health, dispelling common misconceptions and emphasizing the lack of evidence supporting the current warning labels. This episode is a call to action for all healthcare professionals, including primary care physicians, cardiologists, and oncologists, to confidently prescribe these life-saving medications. Get involved and share your voice to help save lives and transform the future of women's health.

 

[madman]

Thread 'FDA Expert Panel on Menopause and HRT Recommends Removing Black Box Labels'

Jul 17, 2025

This was a very important meeting with top experts that are trying to change guidelines. This FDA panel recently recommended removing the warning (“black box”) labels on menopausal HRT, citing potential benefits like reduced heart attack and bone fracture risk—and arguing the warning discourages appropriate use.

FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women​

Hopefully, we will see progress in this field after the confusing and sometimes misleading conclusions of the WHI (“Women’s Health Initiative”), a large National Institutes of Health trial...

• madman
• menopause; hrt; estrogen; testosterone; health
• Replies: 10
• Forum: HRT in Women